Ufp Technologies (UFPT) Free Cash Flow Growth (1y) (2011 - 2026)
Ufp Technologies (UFPT) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -109.40% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 363.84% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -31.71% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 133.09% |
| 10 | Ufp Technologies | 1.92 Bn | 1.90 Bn | 44.36 Mn | -70.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.85% |
| Dec 31, 2025 | -31.06% |
| Sep 30, 2025 | 97.25% |
| Jun 30, 2025 | 151.30% |
| Mar 31, 2025 | 23.21% |
| Dec 31, 2024 | 19.52% |
| Sep 30, 2024 | 38.30% |
| Jun 30, 2024 | 46.49% |
| Mar 31, 2024 | 2,056.58% |
| Dec 31, 2023 | 36.93% |
| Sep 30, 2023 | 729.39% |
| Jun 30, 2023 | 304.39% |
| Mar 31, 2023 | 91.78% |
| Dec 31, 2022 | 3,072.91% |
| Sep 30, 2022 | -186.69% |
| Jun 30, 2022 | -163.28% |
| Mar 31, 2022 | -394.43% |
| Dec 31, 2021 | -107.18% |
| Sep 30, 2021 | -45.15% |
| Jun 30, 2021 | -2.94% |